Elvira Inglese

Dr. Elvira Inglese

Department of Laboratory Medicine, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2017 in OncoImmunology
Verified
Journal Article
Closed access
ABA. Bertaina
A. Bertaina
AZAlessia Zorzoli
Alessia Zorzoli
APAndrea Petretto
Andrea Petretto
GBG. Barbarito
G. Barbarito
EIElvira Inglese
Elvira Inglese
IAIrma Airoldi
Irma Airoldi
We demonstrated that γδ T cells of patients given HLA-haploidentical HSCT after removal of αβ+ T cells and CD19+ B cells are endowed with the capacity of killing leukemia cells after ex vivo treatment with zoledronic acid (ZOL). Thus, we tested the hypothesis that infusion of ZOL in patients receiving this type of graft may enhance γδ T-cell cytotoxic activity against leukemia cells. ZOL was infused every 28 d in 43 patients; most were treated at least twice. γδ T cells before and after ZOL treatments were studied in 33 of these 43 patients, till at least 7 mo after HSCT by high-resolution mass spectrometry, flow-cytometry, and degranulation assay. An induction of Vδ2-cell differentiation, paralleled by increased cytotoxicity of both Vδ1 and Vδ2 cells against primary leukemia blasts was associated with ZOL treatment. Cytotoxic activity was further increased in Vδ2 cells, but not in Vδ1 lymphocytes in those patients given more than one treatment. Proteomic analysis of γδ T cells purified from patients showed upregulation of proteins involved in activation processes and immune response, paralleled by downregulation of proteins involved in proliferation. Moreover, a proteomic signature was identified for each ZOL treatment. Patients given three or more ZOL infusions had a better probability of survival in comparison to those given one or two treatments (86% vs. 54%, respectively, p = 0.008). Our data indicate that ZOL infusion in pediatric recipients of αβ T- and B-cell-depleted HLA-haploidentical HSCT promotes γδ T-cell differentiation and cytotoxicity and may influence the outcome of patients.

22 January 2016 in Scientific Reports
Verified
Journal Article
Open access
CMCecilia Marini
Cecilia Marini
GBGiovanna Bianchi
Giovanna Bianchi
ABAmbra Buschiazzo
Ambra Buschiazzo
Silvia RaveraSilvia Ravera
Silvia Ravera
RMRoberto Martella
Roberto Martella
Gianmario SambucetiGianmario Sambuceti
Gianmario Sambuceti
Emerging evidence demonstrates that targeting energy metabolism is a promising strategy to fight cancer. Here we show that combining metformin and short-term starvation markedly impairs metabolism and growth of colon and breast cancer. The impairment in glycolytic flux caused by starvation is enhanced by metformin through its interference with hexokinase II activity, as documented by measurement of 18F-fluorodeoxyglycose uptake. Oxidative phosphorylation is additively compromised by combined treatment: metformin virtually abolishes Complex I function; starvation determines an uncoupled status of OXPHOS and amplifies the activity of respiratory Complexes II and IV thus combining a massive ATP depletion with a significant increase in reactive oxygen species. More importantly, the combined treatment profoundly impairs cancer glucose metabolism and virtually abolishes lesion growth in experimental models of breast and colon carcinoma. Our results strongly suggest that energy metabolism is a promising target to reduce cancer progression.

3 November 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
APArianna Pani
Arianna Pani
RGRiccardo Giossi
Riccardo Giossi
DMDanilo Menichelli
Danilo Menichelli
VFVeronica Andrea Fittipaldo
Veronica Andrea Fittipaldo
FAFrancesca Agnelli
Francesca Agnelli
Francesco ScaglioneFrancesco Scaglione
Francesco Scaglione
Liver lipid accumulation is a hallmark of non-alcoholic fatty liver disease (NAFLD), broadly associated with insulin resistance. Inositols (INS) are ubiquitous polyols implied in many physiological functions. They are produced endogenously, are present in many foods and in dietary supplements. Alterations in INS metabolism seems to play a role in diseases involving insulin resistance such as diabetes and polycystic ovary syndrome. Given its role in other metabolic syndromes, the hypothesis of an INS role as a supplement in NAFLD is intriguing. We performed a systematic review of the literature to find preclinical and clinical evidence of INS supplementation efficacy in NAFLD patients. We retrieved 10 studies on animal models assessing Myoinosiol or Pinitol deficiency or supplementation and one human randomized controlled trial (RCT). Overall, INS deficiency was associated with increased fatty liver in animals. Conversely, INS supplementation in animal models of fatty liver reduced hepatic triglycerides and cholesterol accumulation and maintained a normal ultrastructural liver histopathology. In the one included RCT, Pinitol supplementation obtained similar results. Pinitol significantly reduced liver fat, post-prandial triglycerides, AST levels, lipid peroxidation increasing glutathione peroxidase activity. These results, despite being limited, indicate the need for further evaluation of INS in NAFLD in larger clinical trials.

12 September 2017 in Proteomics
Verified
Journal Article
Closed access
PDF file
MCMarta Colletti
Marta Colletti
APAndrea Petretto
Andrea Petretto
AGAngela Galardi
Angela Galardi
VPvirginia di paolo
virginia di paolo
LTLuigi Tomao
Luigi Tomao
AGAngela Di Giannatale
Angela Di Giannatale

4 July 2015 in Expert Review of Proteomics
Verified
Journal Article
Closed access
MBMaurizio Bruschi
Maurizio Bruschi
Silvia RaveraSilvia Ravera
Silvia Ravera
LSLaura Santucci
Laura Santucci
GCGiovanni Candiano
Giovanni Candiano
MBMartina Bartolucci
Martina Bartolucci
Isabella PanfoliIsabella Panfoli
Isabella Panfoli
(2015). The human urinary exosome as a potential metabolic effector cargo. Expert Review of Proteomics: Vol. 12, No. 4, pp. 425-432. doi: 10.1586/14789450.2015.1055324

8 December 2017 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
NFNicoletta Ferrari
Nicoletta Ferrari
IGIlaria Granata
Ilaria Granata
MCMatteo Capaia
Matteo Capaia
MPMarina Piccirillo
Marina Piccirillo
MGMario Rosario Guarracino
Mario Rosario Guarracino
PBPaola Barboro
Paola Barboro
Prostate cancer (PCa), the second most common cancer affecting men worldwide, shows a broad spectrum of biological and clinical behaviour representing the epiphenomenon of an extreme heterogeneity. Androgen deprivation therapy is the mainstay of treatment for advanced forms but after few years the majority of patients progress to castration-resistant prostate cancer (CRPC), a lethal form that poses considerable therapeutic challenges. Western blotting, immunocytochemistry, invasion and reporter assays, and in vivo studies were performed to characterize androgen resistant sublines phenotype in comparison to the parental cell line LNCaP. RNA microarray, mass spectrometry, integrative transcriptomic and proteomic differential analysis coupled with GeneOntology and multivariate analyses were applied to identify deregulated genes and proteins involved in CRPC evolution. Treating the androgen-responsive LNCaP cell line for over a year with 10 μM bicalutamide both in the presence and absence of 0.1 nM 5-α-dihydrotestosterone (DHT) we obtained two cell sublines, designated PDB and MDB respectively, presenting several analogies with CRPC. Molecular and functional analyses of PDB and MDB, compared to the parental cell line, showed that both resistant cell lines were PSA low/negative with comparable levels of nuclear androgen receptor devoid of activity due to altered phosphorylation; cell growth and survival were dependent on AKT and p38MAPK activation and PARP-1 overexpression; their malignant phenotype increased both in vitro and in vivo. Performing bioinformatic analyses we highlighted biological processes related to environmental and stress adaptation supporting cell survival and growth. We identified 15 proteins that could direct androgen-resistance acquisition. Eleven out of these 15 proteins were closely related to biological processes involved in PCa progression. Our models suggest that environmental factors and epigenetic modulation can activate processes of phenotypic adaptation driving drug-resistance. The identified key proteins of these adaptive phenotypes could be eligible targets for innovative therapies as well as molecules of prognostic and predictive value.